Anxiolytic and antidepressant properties of methylene blue in animal models

Pharmacological Research

Volumn 36, Issue 5, 1997, Pages 381-385

  Eroglu L ^a   Caglayan B ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Forced swimming test; Methylene blue; Plus maze

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARGININE; CYCLIC GMP; GUANYLATE CYCLASE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; MAZE TEST; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; SWIMMING; TRANQUILIZING ACTIVITY;

EID: 0031280496     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0245     Document Type: Article

References (36)

1. 1. Naylor GJ, Martin B, Hopwood S, Watson YA. Two-year double blind crossover trial of the prophylactic effect of methylene blue in manic depressive psychosis. Biol Psychiatry 1986; 21: 915-20.
2. 2. Naylor GJ, Smith AHW, Connely PA. Controlled trial of methylene blue in manic depressive illness. Biol Psychiat 1987; 25: 657-9.
3. 3. Naylor GJ, Smith AHW. Methylene blue. A new treatment for manic depressive psychosis. IRCS Med Sci 1981; 9: 1154-6.
4. 4. Naylor GJ. Vanadium and manic depressive psychosis. Nutr Health 1984; 3: 79-85.
5. 5. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60-7.
6. 6. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide - a physiological messenger. Ann Intern Med 1994; 120: 227.
7. 7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
8. 8. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992; 266: 68-77.
9. 9. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.
10. 10. Bredt DS, Snyder SH. Isolation of nitric oxide synthase a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-9.
11. 11. Dawson TM, Snyder SH. Gases as biological messengers:nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14: 5147-59.
12. 12. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 1992; 6: 3051-63.
13. 13. Keiner MJ, Bagnell R, Hale B, Alexander NM. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch Biochem Biophys 1988; 262: 422-6.
14. 14. Gerzer R, Böhme E, Hofmann F, Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 1981; 132: 71-4.
15. 15. Mayer B, John M, Heinzel B, Werner R, Wachter H, Schultz G, Böhme E. Brain nitric oxide synthase is a biopterin-and-flavin containing multi-functional oxido-reductase. FEBS Lett 1991; 288: 187-91.
16. 16. Grutter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Relaxation of coronary arterial quanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 1979; 5: 211-24.
17. 17. Ignarro LJ, Kadowytz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985; 25: 171-91.
18. 18. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochemical Pharmacol 1993; 45: 367-74.
19. 19. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G. Methylene blue inhibits vazodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 1990; 254: 872-6.
20. 20. Bauer MB, Murphy S, Gebhart GF. Muscarinic cholinergic stimulation of the nitric oxide cGMP signalling system in cultured rat sensory neurons. Neurosci 1994; 62: 351-9.
21. 21. Young JD, Dyar OS, Xyong L, Zhang J, Gavaghan D. Effect of methylene blue on the vasodilator action of inhaled nitric oxide hypoxic sheep. Brit J Anaest 1994; 73: 511-16.
22. 22. Jhonston AL, File SE. Sex differences in animal tests of anxiety. Physiol Behav 1991; 49: 245-50.
23. 23. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979; 57: 201-10.
24. 24. Dawson RG, Tricklebank MD. Use of the elevated plus-maze in search for novel anxiolytic agents. TIPS 1995; 16: 33-6.
25. 25. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacol 1988; 94: 147-61.
26. 26. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985; 14: 149-67.
27. 1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacol 1992; 106: 484-90.
28. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 1989; 169: 1-10.
29. 29. Willner P. The validity of animal models of depression. Psychopharmacol 1984; 83: 1-16.
30. 30. Porsolt RD, le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatment. Nature 1977; 266: 730-2.
31. 31. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-8.
32. 32. Stephenes D, Meldrum B, Weidman R, Schneider C, Grutzner M. Doses the exitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacol 1986; 90: 166-70.
33. 33. Guimaraes FS, deAquiar JC, Del Bel EA, Ballejo G. Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey. Neuroport 1994; 5: 1929-31.
34. 34. Quock RM, Nguyen E. Possible involvement of nitric oxide in chlordiazepoxide induced anxiolysis in mice. Life Sci 1992; 51: 255-60.
35. 35. Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990; 185: 1-10.
36. 36. Garthwaite J, Boulton CL. Nitric oxyde signaling in the central nervous system. Annu Rev Physiol 1995; 57: 683-706.